Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT06830551
Brief Summary:
The study aim to evaluate the efficacy of cord blood eye drops in the healing of the damaged corneal epithelium.
Detailed Description:
Patients undergoing treatment with EGFR inhibitor for lung cancer might develop corneal damage.
The study aims to evaluate the healing of corneal epithelium by administering cord blood eye drops for one month.
Study:
NCT06830551
Study Brief:
Protocol Section:
NCT06830551